Lethal osteoporosis drug scam — EXPOSED!

How many more studies like this have to come out before mainstream medicine gets a clue — and gets rid of osteoporosis drugs once and for all?

I’ve said it before, but I’ll say it again: Prescription biphosphonates — like Boniva, Fosamax, or Actonel — are a total scam. Unless, of course, you consider a higher risk of fractures to be an acceptable side effect for a drug that’s supposed to strengthen your bone density.

And unfortunately, yet another new study is illustrating this lethal catch-22.

As part of a recent review published in Current Geriatrics Reports, a team of orthopedic surgeons gave a rundown on the risks of popular osteoporosis medications. Their focus was on atypical femur fractures — a break in the thigh bone that occurs with little or no force. (But a whole lot of pain.)

On average, the researchers found these fractures started cropping up within three years of starting osteoporosis drugs. And these doctors propose “immediate cessation of biphosphonates” as the first step in treating atypical femur fractures.

Gee… you think?! How about just not using biphosphonates in the first place?

This review shines a much-needed spotlight on the lethal impact osteoporosis fractures can have in older adults. But research has proven, beyond a shadow of any doubt, that bisphosphonate drugs can CAUSE these fractures. So to suggest that they have any role in osteoporosis prevention borders on malpractice, if you ask me.

Particularly when you don’t need them at all. These researchers mention calcium and vitamin D as risk-free alternatives — and that’s certainly a good start. But if you want complete protection, don’t stop there.

As I’ve mentioned before, vitamin K is a critical ally. So is potassium citrate. And as I reminded you on Tuesday, don’t forget to get plenty of magnesium, too.

All of these simple nutrients strengthen your bones against fractures. And best of all, they won’t break the bank — or your femur.

Source:

https://www.sciencedaily.com/releases/2016/03/160301075308.htm


CLOSE
CLOSE